Lv M, Zhang X, Shen Y, et al. Clinical analysis and prognosis of synchronous and metachronous multiple primary malignant tumors[J]. Medicine (Baltimore),2017,96(17):e6799.
[2]
Lv M, Zhang X, Shen Y, et al. Clinical analysis and prognosis of synchronous and metachronous multiple primary malignant tumors[J]. Medicine (Baltimore),2017,96(17):e6799.
[3]
Antakli T, Schaefer R F, Rutherford J E, et al. Second primary lung cancer[J]. Ann Thorac Surg, 1995, 59(4):863-867.
[3]
Antakli T, Schaefer R F, Rutherford J E, et al. Second primary lung cancer[J]. Ann Thorac Surg, 1995, 59(4):863-867.
[4]
Utada M, Ohno Y, Hori M, et al. Incidence of multiple primary cancers and interval between first and second primary cancers[J].Cancer Sci, 2014, 105(7),890-896.
[4]
Utada M, Ohno Y, Hori M, et al. Incidence of multiple primary cancers and interval between first and second primary cancers[J].Cancer Sci, 2014, 105(7),890-896.
[5]
Donin NM, Kwan L, Lenis AT, et al. Second primary lung cancer in United States cancer survivors, 1992-2008[J].Cancer Causes Control, 2019, 30(5),465-475.
[5]
Donin NM, Kwan L, Lenis AT, et al. Second primary lung cancer in United States cancer survivors, 1992-2008[J].Cancer Causes Control, 2019, 30(5),465-475.
Gregoire J. Guiding principles in the management of synchronous and metachronous primary non-small cell lung cancer[J].Thorac Surg Clin, 2021, 31(3):237-254.
[18]
Gregoire J. Guiding principles in the management of synchronous and metachronous primary non-small cell lung cancer[J].Thorac Surg Clin, 2021, 31(3):237-254.